NASDAQ: CNTB
Connect Biopharma Holdings Ltd Stock Ownership - Who owns Connect Biopharma Holdings?

Insider buying vs selling

Have Connect Biopharma Holdings Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CNTB insiders and whales buy or sell their stock.

CNTB Shareholders

What type of owners hold Connect Biopharma Holdings Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bml Capital Management LLC3.78%2,093,232$1.70MInstitution
Oconnor A Distinct Business Unit Of Ubs Asset Management Americas LLC0.92%510,701$413.67kInstitution
Choreo LLC0.29%160,867$130.30kInstitution
Renaissance Technologies LLC0.24%134,697$109.10kInstitution
Royal Bank Of Canada0.15%80,400$65.12kInstitution
Callan Capital LLC0.14%80,000$64.80kInstitution
Catalina Capital Group LLC0.09%47,867$38.77kInstitution
Geode Capital Management LLC0.05%27,961$22.65kInstitution
Commonwealth Equity Services LLC0.04%20,000$16.20kInstitution
Geowealth Management LLC0.02%10,942$8.86kInstitution

1 of 2

CNTB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CNTB5.75%0.00%
MURA54.89%3.40%Net SellingNet Selling
ONCY1.64%0.00%
BRNS24.09%54.05%
CLLS45.57%0.00%

Connect Biopharma Holdings Stock Ownership FAQ

Who owns Connect Biopharma Holdings?

Connect Biopharma Holdings (NASDAQ: CNTB) is owned by 5.75% institutional shareholders, 0.00% Connect Biopharma Holdings insiders, and 94.25% retail investors. Bml Capital Management LLC is the largest individual Connect Biopharma Holdings shareholder, owning 2.09M shares representing 3.78% of the company. Bml Capital Management LLC's Connect Biopharma Holdings shares are currently valued at $1.72M.

If you're new to stock investing, here's how to buy Connect Biopharma Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.